Acton Pharmaceuticals' Series A - IV Round

Acton Pharmaceuticals raised a round of funding on May 20, 2013. Investors include Sequoia Capital.

Acton Pharmaceuticals, is primarily focused on development and commercialization of pharmaceutical products that treat allergic, pulmonary, and other respiratory related diseases.…

Articles about Acton Pharmaceuticals' Series A - IV Round: